Promiscuous Enzyme Activity as a Driver of Allo and Iso Convergent Evolution, Lessons from the β-Lactamases.
antibiotic resistance
convergent evolution
β-lactamase
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Aug 2020
29 Aug 2020
Historique:
received:
01
07
2020
revised:
17
08
2020
accepted:
26
08
2020
entrez:
3
9
2020
pubmed:
3
9
2020
medline:
24
2
2021
Statut:
epublish
Résumé
The probability of the evolution of a character depends on two factors: the probability of moving from one character state to another character state and the probability of the new character state fixation. The more the evolution of a character is probable, the more the convergent evolution will be witnessed, and consequently, convergent evolution could mean that the convergent character evolution results as a combination of these two factors. We investigated this phenomenon by studying the convergent evolution of biochemical functions. For the investigation we used the case of β-lactamases. β-lactamases hydrolyze β-lactams, which are antimicrobials able to block the DD-peptidases involved in bacterial cell wall synthesis. β-lactamase activity is present in two different superfamilies: the metallo-β-lactamase and the serine β-lactamase. The mechanism used to hydrolyze the β-lactam is different for the two superfamilies. We named this kind of evolution an allo-convergent evolution. We further showed that the β-lactamase activity evolved several times within each superfamily, a convergent evolution type that we named iso-convergent evolution. Both types of convergent evolution can be explained by the two evolutionary mechanisms discussed above. The probability of moving from one state to another is explained by the promiscuous β-lactamase activity present in the ancestral sequences of each superfamily, while the probability of fixation is explained in part by positive selection, as the organisms having β-lactamase activity allows them to resist organisms that secrete β-lactams. Indeed, an organism that has a mutation that increases the β-lactamase activity will be selected, as the organisms having this activity will have an advantage over the others.
Identifiants
pubmed: 32872436
pii: ijms21176260
doi: 10.3390/ijms21176260
pmc: PMC7504333
pii:
doi:
Substances chimiques
beta-Lactams
0
beta-Lactamases
EC 3.5.2.6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale de la Recherche
ID : Méditerranée Infection 10-IAHU-03
Références
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Trends Biochem Sci. 1994 Jan;19(1):15-8
pubmed: 8140615
J Mol Biol. 2006 Sep 1;361(5):1003-34
pubmed: 16889794
Evol Appl. 2019 Jul 18;12(9):1812-1822
pubmed: 31548859
Annu Rev Biochem. 2010;79:471-505
pubmed: 20235827
Nature. 2011 Aug 31;477(7365):457-61
pubmed: 21881561
Curr Opin Struct Biol. 2017 Dec;47:167-175
pubmed: 29169066
J Biol Chem. 2008 May 9;283(19):12769-76
pubmed: 18337244
Biol Direct. 2011 Feb 18;6:11
pubmed: 21333002
Science. 2002 Jun 14;296(5575):1982-3
pubmed: 12065824
Biochem Pharmacol. 2007 Dec 15;74(12):1686-701
pubmed: 17597585
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
Anal Biochem. 2014 Oct 15;463:15-22
pubmed: 24945954
Curr Opin Chem Biol. 2016 Dec;35:97-108
pubmed: 27693891
J Gen Microbiol. 1983 May;129(5):1247-60
pubmed: 6352855
Inorg Chem. 2012 Nov 19;51(22):12419-25
pubmed: 23113650
Trends Microbiol. 2016 Jan;24(1):12-25
pubmed: 26578093
Evol Dev. 2001 Mar-Apr;3(2):73-83
pubmed: 11341676
J Mol Evol. 2014 Oct;79(3-4):117-29
pubmed: 25185655
Nucleic Acids Res. 2015 Jan;43(Database issue):D222-6
pubmed: 25414356
Database (Oxford). 2019 Jan 1;2019:
pubmed: 31650170
Emerg Microbes Infect. 2019;8(1):1688-1700
pubmed: 31749408
J Biol Chem. 2001 Aug 24;276(34):31494-501
pubmed: 11408478
Sci Rep. 2020 Dec 10;10(1):21685
pubmed: 33303919
Evolution. 2011 Jul;65(7):1827-40
pubmed: 21729041
PLoS One. 2009;4(2):e4345
pubmed: 19190775
Nature. 2019 May;569(7754):79-84
pubmed: 30971819
Genome Biol Evol. 2018 Apr 1;10(4):1106-1114
pubmed: 29672703
Bioinformatics. 2009 Aug 1;25(15):1972-3
pubmed: 19505945
Drug Resist Updat. 2004 Apr;7(2):111-23
pubmed: 15158767
Annu Rev Microbiol. 2011;65:631-58
pubmed: 21740227
J Biol Chem. 2007 Jun 22;282(25):18286-18293
pubmed: 17403673
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30783007
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
J Biol Chem. 2012 Jan 2;287(1):11-20
pubmed: 22069329
Annu Rev Microbiol. 1976;30:409-25
pubmed: 791073
J Mol Biol. 2014 Jun 26;426(13):2442-56
pubmed: 24769192
Anal Biochem. 2013 Aug 1;439(1):37-43
pubmed: 23603065
J Mol Biol. 2007 Sep 21;372(3):817-45
pubmed: 17681532
Sci Rep. 2019 Aug 21;9(1):12173
pubmed: 31434986
Nucleic Acids Res. 2016 Jan 4;44(D1):D343-50
pubmed: 26527717
Evolution. 2011 Mar;65(3):629-42
pubmed: 21054357
Antimicrob Agents Chemother. 1998 Jan;42(1):1-17
pubmed: 9449253
PLoS One. 2017 Jul 27;12(7):e0182043
pubmed: 28750094